Sponsors (2)
The bill strengthens international biodefense coordination and biosafety—improving detection and limiting adversaries' access to risky materials—while imposing stronger export controls, potential diplomatic friction, higher costs, and reduced transparency that may slow research and raise taxpayer burdens.
State and local governments and taxpayers will benefit from closer coordination with U.S. allies and partners on biodefense, improving early detection and response to biological threats.
U.S. national security is strengthened by coordinated export controls on dual‑use biotechnology items that limit adversaries' access to materials that could enable bioweapon development.
Scientists and public health systems (particularly in partner countries) could adopt higher biosafety and biosecurity standards, reducing the risk of accidental or illicit release of biological agents.
Scientists and hospitals may face slower legitimate international collaboration and higher compliance costs because of stronger export controls and biotechnology restrictions.
Taxpayers could see increased costs if expanded NATO biodefense activities and capability development require higher defense spending or reallocation of resources.
Classified annexes and security-focused coordination may reduce transparency and public oversight of certain biodefense activities, limiting accountability.
Based on analysis of 2 sections of legislative text.
Requires the State Department to expand diplomacy with NATO and allies on biodefense, pursue NATO CBRN policy changes, and produce NATO and international biodefense cooperation strategies.
Official title: Enhance diplomatic engagement on international biotechnology and biosecurity matters.
Introduced May 12, 2026 by Timothy Patrick Sheehy · Last progress May 12, 2026
Directs the State Department to lead expanded U.S. diplomacy with NATO and other allies on biodefense, biosecurity, and biotechnology. It requires the department to push for stronger NATO planning, interoperable capabilities for detection, attribution, response and recovery from biological attacks, revisions to NATO CBRN policy, and higher safety standards for biological research, and to produce two strategies: a NATO Biodefense Strategy and an International Biotechnology, Biosecurity, and Biodefense Cooperation Strategy.